Marinaki AM - Search Results

1

Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis.

Campalani E, Arenas M, Marinaki AM, Lewis CM, Barker JN, Smith CH. Campalani E, et al. Among authors: marinaki am. J Invest Dermatol. 2007 Aug;127(8):1860-7. doi: 10.1038/sj.jid.5700808. Epub 2007 Apr 5. J Invest Dermatol. 2007. PMID: 17410198 Free article.

2

Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study.

Woolf RT, West SL, Arenas-Hernandez M, Hare N, Peters van Ton AM, Lewis CM, Marinaki AM, Barker JN, Smith CH. Woolf RT, et al. Among authors: marinaki am. Br J Dermatol. 2012 Jul;167(1):165-73. doi: 10.1111/j.1365-2133.2012.10881.x. Br J Dermatol. 2012. PMID: 22309614

3

Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity.

Arenas M, Simpson G, Lewis CM, Shobowale-Bakre el-M, Escuredo E, Fairbanks LD, Duley JA, Ansari A, Sanderson JD, Marinaki AM. Arenas M, et al. Among authors: marinaki am. Clin Chem. 2005 Dec;51(12):2371-4. doi: 10.1373/clinchem.2005.053157. Clin Chem. 2005. PMID: 16306100 No abstract available.

4

Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).

Marinaki AM, Ansari A, Duley JA, Arenas M, Sumi S, Lewis CM, Shobowale-Bakre el-M, Escuredo E, Fairbanks LD, Sanderson JD. Marinaki AM, et al. Pharmacogenetics. 2004 Mar;14(3):181-7. doi: 10.1097/00008571-200403000-00006. Pharmacogenetics. 2004. PMID: 15167706

5

Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.

Breen DP, Marinaki AM, Arenas M, Hayes PC. Breen DP, et al. Among authors: marinaki am. Liver Transpl. 2005 Jul;11(7):826-833. doi: 10.1002/lt.20377. Liver Transpl. 2005. PMID: 15973722 Free article.

6

Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity.

Wee JS, Marinaki A, Smith CH. Wee JS, et al. BMJ. 2011 Mar 25;342:d1417. doi: 10.1136/bmj.d1417. BMJ. 2011. PMID: 21441287 No abstract available.

7

Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease.

Smith MA, Marinaki AM, Arenas M, Shobowale-Bakre M, Lewis CM, Ansari A, Duley J, Sanderson JD. Smith MA, et al. Among authors: marinaki am. Aliment Pharmacol Ther. 2009 Aug 15;30(4):375-84. doi: 10.1111/j.1365-2036.2009.04057.x. Epub 2009 Jun 3. Aliment Pharmacol Ther. 2009. PMID: 19500084

8

Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.

Loganayagam A, Arenas Hernandez M, Corrigan A, Fairbanks L, Lewis CM, Harper P, Maisey N, Ross P, Sanderson JD, Marinaki AM. Loganayagam A, et al. Among authors: marinaki am. Br J Cancer. 2013 Jun 25;108(12):2505-15. doi: 10.1038/bjc.2013.262. Epub 2013 Jun 4. Br J Cancer. 2013. PMID: 23736036 Free PMC article.

9

Purine nucleoside phosphorylase deficiency: a mutation update.

Walker PL, Corrigan A, Arenas M, Escuredo E, Fairbanks L, Marinaki A. Walker PL, et al. Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1243-7. doi: 10.1080/15257770.2011.630852. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132981

10

Typing TPMT and ITPase to detect azathioprine toxicity.

Arenas M, Marinaki A, Ansari A, Sanderson J. Arenas M, et al. Per Med. 2006 Feb;3(1):45-59. doi: 10.2217/17410541.3.1.45. Per Med. 2006. PMID: 29783434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters